SCENESSE

*** WARNING - THIS SITE IS EXPERIMENTAL. DATA NOT GUARANTEED ACCURATE. ***
Quick Summary
Status: 700 - REGISTERED
Serial Number: 79229902
Status Date: 16 Apr 2019
Filing Date: 13 Feb 2018
Published for Opposition Date: 29 Jan 2019
Registration Number: 5724241
Registration Date: 16 Apr 2019
Register: Principal
Typed drawing
Details
Indication of Colors Claimed: Color is not claimed as a feature of the mark
Description of Mark:
Design Code(s):
Mark Type: Trademark
Filing Basis:
Current Basis:
Disclaimer(s): N/A
Translation(s): N/A
Pseudo Mark(s): N/A
Registration Class(es)

Primary Class 003

Goods and Services: Cosmetic preparations for skin care, based on analogues of melanocyte-stimulating hormone (MSH), in particular afamelanotide; non-medicated sun tanning preparations based on analogues of melanocyte-stimulating hormone (MSH), in particular afamelanotide; cosmetics for tanning the skin, namely, cosmetics for tanning the skin based on analogues of melanocyte-stimulating hormone (MSH), in particular afamelanotide, and preparations for tanning without sunlight based on analogues of melanocyte-stimulating hormone (MSH), in particular afamelanotide
International Class Codes: 003
US Class Codes: 001, 004, 006, 050, 051, 052
Class Status Code: 6
Class Status Date: 10 Apr 2018
First Use Anywhere Date: N/A
First Use In Commerce Date: N/A

Primary Class 005

Goods and Services: Pharmaceutical preparations, based on analogues of melanocyte-stimulating hormone (MSH), in particular afamelanotide, for skin care and for treating skin and skin relating conditions and disorders; medicated sun tanning preparations for pharmaceutical purposes, based on analogues of melanocyte-stimulating hormone (MSH), in particular afamelanotide; chemical and biological preparations, substances, reagents and compounds, namely, drug delivery agents consisting of compounds that facilitate the delivery of pharmaceuticals which are based on analogues of melanocyte-stimulating hormone (MSH), in particular afamelanotide, and pharmaceutical preparations based on analogues of melanocyte-stimulating hormone (MSH), in particular afamelanotide, for use in dermatology, for skin care, for the treatment of skin disorders, for the protection of the dermis and epidermis used in the manufacture, delivery and storage of pharmaceuticals, drugs and diagnostic preparations
International Class Codes: 005
US Class Codes: 006, 018, 044, 046, 051, 052
Class Status Code: 6
Class Status Date: 10 Apr 2018
First Use Anywhere Date: N/A
First Use In Commerce Date: N/A
International Registration
International Registration Number 1055163
International Registration Date 10 May 2010
International Publication Date 05 Apr 2018
International Renewal Date 10 May 2020
Auto Protection Date 05 Oct 2019
International Death Date N/A
International Status Code 001
International Status Date 05 Apr 2018
Priority Claimed In F
Priority Claimed Date N/A
First Refusal In T
Ownership
Party Name Party Type Legal Entity Type Address
Clinuvel Pharmaceuticals Limited 10 - Original Applicant 99 - Other Level 11, 330 Collins Street Melbourne, VIC 3000, , ,
Clinuvel Pharmaceuticals Limited 20 - Owner at Publication 99 - Other Level 11, 330 Collins Street Melbourne, VIC 3000, , ,
Clinuvel Pharmaceuticals Limited 30 - Original Registrant 99 - Other Level 11, 330 Collins Street Melbourne, VIC 3000, , ,
Events
Date Description Event Type Event Code
05 Apr 2018 SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB M SDRC
09 Apr 2018 LIMITATION FROM ORIGINAL APPLICATION ENTERED I LIMI
10 Apr 2018 NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM I NWOS
14 Apr 2018 APPLICATION FILING RECEIPT MAILED O MAFR
29 May 2018 ASSIGNED TO EXAMINER D DOCK
31 May 2018 NON-FINAL ACTION WRITTEN R CNRT
01 Jun 2018 NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW E RFCR
07 Jun 2018 REFUSAL PROCESSED BY MPU P RFRR
07 Jun 2018 NON-FINAL ACTION MAILED - REFUSAL SENT TO IB P RFCS
29 Jun 2018 REFUSAL PROCESSED BY IB P RFNT
03 Dec 2018 TEAS RESPONSE TO OFFICE ACTION RECEIVED I TROA
03 Dec 2018 CORRESPONDENCE RECEIVED IN LAW OFFICE I CRFA
04 Dec 2018 TEAS/EMAIL CORRESPONDENCE ENTERED I TEME
05 Dec 2018 APPROVED FOR PUB - PRINCIPAL REGISTER O CNSA
26 Dec 2018 ASSIGNED TO LIE A ALIE
09 Jan 2019 NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED E NONP
09 Jan 2019 NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB P OP2R
09 Jan 2019 NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB P OPNS
11 Jan 2019 TOTAL INVALIDATION PROCESSED BY THE IB P INNT
29 Jan 2019 PUBLISHED FOR OPPOSITION A PUBO
29 Jan 2019 OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED E NPUB
01 Mar 2019 NOTIFICATION PROCESSED BY IB P GPNX
16 Apr 2019 REGISTERED-PRINCIPAL REGISTER A R.PR